Table 2

Demographic and baseline clinical characteristics

Characteristic

Hydromorphone (N = 99)

Morphine (N = 101)


Mean (SD) age, years

60.7 (12.50)

59.0 (11.36)


Gender, % male

46.5

51.5


Race, % Caucasian/Black/Asian/Other

100/0/0/0

97/0/2/1


Mean (SD) height, cm

166.7 (9.33)

167.3 (10.47)


Mean (SD) weight, kg

66.3 (15.33)

67.4 (13.33)


Mean (SD) BMI, kg/m2

23.8 (5.14)

24.2 (5.06)


Cancer type, n (%)

Breast

23 (23.2)

33 (32.7)

Lung

20 (20.2)

19 (18.8)

Genitourinary

18 (18.2)

12 (11.9)

Gastrointestinal

17 (17.2)

15 (14.9)

Oral cavity

3 (3.0)

3 (3.0)

Lymphoma

3 (3.0)

0

Leukemia

1 (1.0)

2 (2.0)

Bone

1 (1.0)

1 (1.0)

Other

13 (13.1)

16 (15.8)


Predominant pain type, n (%)

Bone or soft tissue

61 (61.6)

72 (71.3)

Mixed

19 (19.2)

15 (14.9)

Visceral

19 (19.2)

14 (13.9)


Mean (SD) MMSE score*

28.5 (2.3)

28.8 (2.0)


Mean (SD) ECOG score

1.6 (0.8)

1.6 (0.9)


Abbreviations: BMI, body mass index; ECOG, Eastern Cooperative Oncology Group; MMSE, Mini-Mental State Examination; SD, standard deviation

*Hydromorphone, n = 75; morphine, n = 73

Hanna et al. BMC Palliative Care 2008 7:17   doi:10.1186/1472-684X-7-17

Open Data